White Cliff Minerals completes the divestment of Great Bear Project, receiving A$1.2m cash and retaining a 9.99% equity stake in the emerging copper system at Rae.
Reach Resources secures $6.05 million in funding to accelerate development at its Murchison South Gold Project in Western Australia.
Australian Oil Company advances Surat Basin production with a second 422-barrel lifting from Emu Apple and gas field mapping nearing completion.
Critical Resources confirms high-grade gold-antimony mineralisation in both historic workings and in-situ bedrock at its Croesus Project in New Zealand.
Argenica clears the final FDA safety assay for ARG-007 (xaranetide), paving the way for US clinical trials in acute stroke.
Leeuwin Metals enters a collaborative framework with Bain and MEGA to evaluate development, mining, processing, and funding pathways for the Marda Gold Project.
Antares Metals has begun its maiden drilling at the Conglomerate Creek prospect in Mount Isa North, targeting seven untested high-priority geophysical anomalies.
WHO confirms “xaranetide” as the International Nonproprietary Name for Argenica’s lead neuroprotective candidate, ARG-007.
Impact Minerals Phase 2 drilling at Commonwealth–Silica Hill Project set to commence in early July following a successful high-grade Phase 1 campaign.
Critical Resources identifies 14 pegmatite bodies, including six previously unmapped, in its northern Mavis Lake Lithium corridor.
